Clinical Trials Directory

Trials / Suspended

SuspendedNCT01443559

Xenogenic Keratoplasty From Porcine Cornea

Phase I Study of Xenogenic Keratoplasty From Porcine Cornea in the Treatment of Infectious Corneal Ulcer

Status
Suspended
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Xiamen University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Acellular porcine cornea is a valid substitution for human cornea because of its similar biological structure, corneal superficial curvature and good histocompatibility toward human. Facing the lack of human cornea donor, it is hypothesised that using acellular lamellar porcine cornea as an alternative of lamellar human cornea to treat infectious corneal ulcer.

Detailed description

Acellular porcine cornea eligibility criteria: 1. fresh porcine cornea, 2. porcine cornea keeping transparent without scar, neovascularization or corneal ulcer, 3. porcine cornea keeping integrative corneal epithelium and endothelium, 4. acellular porcine cornea keeping transparent.

Conditions

Interventions

TypeNameDescription
GENETICXenogenic cornealamellar acellular xenogenic corneas were sterilised by radiation
GENETIChomogenic corneahomogenic corneas were sterilised by radiation

Timeline

Start date
2011-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-09-29
Last updated
2015-07-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01443559. Inclusion in this directory is not an endorsement.